Long-term sequential treatment with combined estradiol valerate and cyproterone acetate in early postmenopause

Acta Obstetricia et Gynecologica Scandinavica

Volumn 78, Issue 1, 1999, Pages 49-53

  Polatti, Franco ^a   Capuzzo, Ezio ^a   Viazzo, Franco ^a   Colleoni, Rossella ^a   Abbiati, Ileana ^a   Nappi, Rossella E ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Climacteric; Cyproterone acetate; Estradiol valerate

Indexed keywords

BIOCHEMICAL MARKER; CYPROTERONE ACETATE; CYPROTERONE ACETATE PLUS ESTRADIOL VALERATE; ESTRADIOL VALERATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CHOLESTEROL BLOOD LEVEL; CLIMACTERIUM; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; ENDOMETRIUM; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYSTEROSCOPY; LIPID BLOOD LEVEL; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0032896572     PISSN: 00016349     EISSN: None     Source Type: Journal    
DOI: 10.1080/j.1600-0412.1999.780111.x     Document Type: Article

References (20)

1. 1. Kiel DP, Felson DT, Anderson JJ, Wilson PWF, Moskowitz MA. Hip fracture and the use of estrogens in postmenopausal women. N Engl J Med 1987; 317: 1169-74.
2. 2. Jensen PB, Jensen J, Riis BJ, Rodbro P, Strom V, Christiansen C. Climacteric symptoms after oral and percutaneous hormone replacement therapy. Maturitas 1987; 9: 207-15.
3. 3. Sporrong T, Hellgren M, Samsioe G, Mattson LA. Comparison of four continuously administered progestogens plus oestradiol combinations for climacteric complaints. Br J Obstet Gynaecol 1988; 95: 1042-8.
4. 4. Marslew U, Overgaard K, Riis BJ, Christiansen C. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms and bleeding. Obstet Gynecol 1992; 79: 202-10.
5. 5. Schwartz U, Volger H, Schneller E, Moltz L, Hammerstein J. Effects of various replacement estrogens on hepatic transcortin synthesis in climacteric women. Acta Endocrinol 1983; 102: 103-6.
6. 6. Enk L, Siliverstolpe G, Crona N. Dose and duration effects of estradiol valerate on serum apolipoproteins A1 and B. Maturitas 1987; 9: 33-9.
7. 7. Crona N, Silfverstolpe G, Samsioe G. A double blind crossover study on the effects of ORG OD 14 compared to estradiol valerate and placebo on lipid and carbohydrate metabolism in oophorectomized women. Acta Endocrinol 1983; 102: 451-5.
8. 8. Anton FM, Garcia-Puig J, Ramos T, Gonzales P, Ordas J. Sex differences in uric acid metabolism in adults: evidence of lack of influence of estradiol 17 beta on renal hangling of urate. Metabolism 1986; 35: 343-8.
9. 9. Barentsen R, Van De Weijer PHM. Progestogens: pharmacological characteristics and clinically relevant differences. Eur Menopause J 1996; 3: 226-71.
10. 10. Koninckx PR, Lanweryns JM, Cornillie FJ. Endometrial effects during hormone replacement therapy with a sequential oestradiol valerate/cyproterone acetate preparation. Maturitas 1993; 16: 97-110.
11. 11. Neuman F. The physiological action of progesterone and the pharmacological effects of progestogens - a short review. Postgrad Med 1978; 54: 11-24.
12. 12. Kaiser E, Gruner HS. Liver structure and function during long-term treatment with CPA. Arch Gynecol 1987; 240: 217-23.
13. 13. Kupperman HS, Blatt MHG, Weisbader H, Filler W. Comparative clinical evaluation of estrogenic preparations by the menopausal and amenorrheal indices. J Clin Endocrinol 1953; 13: 688-703.
14. 14. Riis BJ, Jensen J, Christiansen C. Cyproterone acetate, an alternative gestagen in postmenopausal oestrogen/gestagen therapy. Clin Endocrinol 1987; 26: 327-34.
15. 15. Gambacciani M, Spinetti A, Orlandi R, Piaggesi L, Cappagli B, Weiss C et al. Effects of a new estrogen-progestin combination in the treatment of postmenopausal syndrome. Maturitas 1995; 22: 115-20.
16. 16. Goh HH, McCarthy TG, Dramusic V, Costales A, Junge W, Ratnam SS. Endocrine effects in Asian postmenopausal women treated with SH D 461 M and Prempak-C. Maturitas 1995; 21: 17-25.
17. 17. QuCreux C, Abramovici Y, Bohec M. Menopause et facteurs de risque cardiovasculaire: effect de Climen sur le poids, la pression arterielle et les paramètres lipidiques. [Menopause and cardiovascular risk factors: effect of Climen on weight, arterial blood pressure and lipid parameters.] Reprod Hum Horm 1994; 7: 1-8.
18. 18. Silfverstolpe G, Gustafson A, Samsioe G, Svanborg A. Lipid metabolic studies in oophorectomised women: effect on serum lipids and lipoproteins of three synthetic progestogens. Maturitas 1982; 4: 103-11.
19. 19. De Aloysio D, Fabiani AG, Mauloni M, Miliffi L, Bottiglioni F. Oestrogen-antiandrogen treatment of naturally postmenopausal women. Acta Therapeutica 1988; 14: 171-88.
20. 20. Hirvonen E, Elliesen J, Schmidt-Gollwitzer K. Comparison of two hormone replacement regimens - Influence on lipoproteins and bone mineral content. Maturitas 1990; 12: 127-36.